|
Classification of AFP cases
|
Age (years)
|
No.
|
0 dose
|
1-2 doses
|
≥ 3 doses
|
Unknown
|
|---|
|
N (%)
|
N (%)
|
N (%)
|
N (%)
|
|---|
|
WPV cases
|
< 1
|
6
|
3 (50.0)
|
1 (16.7)
|
2 (33.3)
|
0 (0)
|
|
1-4
|
4
|
0 (0)
|
1 (25.0)
|
3 (75.0)
|
0 (0)
|
|
5-14
|
0
|
0 (0)
|
0 (0)
|
0 (0)
|
0 (0)
|
|
15-39
|
10
|
2 (20.0)
|
1 (10.0)
|
0 (0)
|
7 (70.0)
|
|
≥ 40
|
1
|
0 (0)
|
0 (0)
|
0 (0)
|
1 (100.0)
|
|
Total
|
21
|
5 (23.8)
|
3 (14.3)
|
5 (23.8)
|
8 (38.1)
|
|
Clinical compatible polio cases
|
< 1
|
3
|
2 (66.7)
|
0 (0)
|
1 (33.3)
|
0 (0)
|
|
1-4
|
3
|
0 (0)
|
1 (33.3)
|
2 (66.7)
|
0 (0)
|
|
5-14
|
1
|
0 (0)
|
0 (0)
|
0 (0)
|
1 (100.0)
|
|
15-39
|
14
|
1 (7.1)
|
1 (7.1)
|
1 (7.1)
|
11 (78.6)
|
|
≥ 40
|
2
|
0 (0)
|
0 (0)
|
0 (0)
|
2 (100.0)
|
|
Total
|
23
|
3 (13.0)
|
2 (8.7)
|
4 (17.4)
|
14 (60.9)
|
|
Non-polio AFP cases
|
< 1
|
19
|
2 (10.5)
|
7 (36.8)
|
8 (42.1)
|
2 (10.5)
|
|
1-4
|
73
|
0 (0)
|
1 (1.4)
|
63 (86.3)
|
9 (12.3)
|
|
5-14
|
56
|
1 (1.8)
|
1 (1.8)
|
38 (67.9)
|
16 (28.6)
|
|
15-39
|
200
|
7 (3.5)
|
23 (11.5)
|
8 (4.0)
|
161 (81.0)
|
|
≥ 40
|
186
|
16 (8.6)
|
2 (1.1)
|
1 (0.5)
|
167 (89.8)
|
| |
Total
|
534
|
26 (4.9)
|
34 (6.4)
|
118 (22.1)
|
356 (66.7)
|
- Note: OPV oral attenuated poliovirus vaccine, AFP acute flaccid paralysis, WPV wild poliovirus.
